Phase 4Completed

Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)

SCH 58235: A Multicentre, Randomised, Parallel Group, Placebo-Controlled Study Comparing the Efficacy, Safety, And Tolerability of the Daily Co-Administration of Ezetimibe 10 mg With Atorvastatin 10 mg vs. Ezetimibe Placebo With Atorvastatin 10 mg in Untreated Subjects With Primary Hypercholesterolaemia and Coronary Heart Disease

Sponsor
Organon and Co (Industry)
Enrollment
148 enrolled
Conditions
Hypercholesterolemia; Atherosclerosis
Interventions
Ezetimibe + Atorvastatin; Atorvastatin
Ages
adults, older adults
Registry
NCT00653796

Full record on ClinicalTrials.gov

From the registry

This study was designed to assess whether co-administration of ezetimibe 10 mg with atorvastatin 10 mg in treatment naïve subjects would be more effective than treatment with atorvastatin 10 mg alone for reducing LDL-concentrations.

Primary outcomes

  • Percent change in LDL-C from baseline to endpoint.

History

  1. Last registry update

  2. Registered

  3. Primary completion

  4. Started